United States. Securities and Exchange Commission
Salisbury Bancorp, Inc. has entered into an Agreement and Plan of Merger with NBT Bancorp Inc. to be acquired by NBT. The agreement was filed with the Securities and Exchange Commission (SEC) on December 5, 2022. Under the terms of the merger, each outstanding share of Salisbury common stock will
United States. Securities and Exchange Commission
According to a recent U.S. Securities and Exchange Commission filing, Amgen Inc. disclosed information regarding the company's director, officer, or owner of more than 10% of a class of equity securities registered under Section 12 of the '34 Act. The filing, made on November 10, 2022,
United States. Securities and Exchange Commission
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, has announced that its partner Genentech has launched a Phase 2a clinical study of OpRegen (RG6501), a retinal pigment epithelial cell therapy, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The study aims to evaluate the safety
United States. Securities and Exchange Commission
Amgen Inc., a leading biopharmaceutical company, recently submitted a U.S. Securities and Exchange Commission (SEC) filing (Form 8-K) on November 3, 2022, reporting material events and corporate changes. This filing, which includes 16 documents, is available for public review on the SEC's website. As a biotech leader,
United States. Securities and Exchange Commission
Moderna, Inc., a biotechnology company, has filed a document with the U.S. Securities and Exchange Commission (SEC) detailing its equity securities and beneficial ownership. The filing, made on November 4, 2022, provides insight into the company's ownership structure and transactions involving its directors, officers, and major shareholders.
United States. Securities and Exchange Commission
The Federal Home Loan Bank of San Francisco has filed an amended Form 8-K with the Securities and Exchange Commission on November 14, 2022, to provide additional information regarding the compensation of Gregory A. Ward, the Executive Vice President and Chief Operating Officer. The amended report supplements the original Form
United States. Securities and Exchange Commission
On November 9, 2022, Automatic Data Processing, Inc. held its Annual Meeting of Stockholders, where key resolutions were voted on by shareholders. The meeting saw significant participation, with present holders of 368,113,135 shares of common stock. The results of the voting for various proposals are outlined below. Key
United States. Securities and Exchange Commission
Cambridge Bancorp, a Massachusetts-based bank, has successfully completed its acquisition of Northmark Bank, a move aimed at expanding its presence in the region. The deal, announced in May 2022, was completed on October 1, 2022, as per the terms of the Agreement and Plan of Merger. The acquisition marks a
United States. Securities and Exchange Commission
Gina Stryker, a member of the Audit Committee of TMC the Metals Company Inc.'s Board of Directors, has resigned effective September 27, 2022, after serving since the company's business combination transaction in September 2021. Her departure was not due to any disagreement with the company. Stryker
United States. Securities and Exchange Commission
The Securities and Exchange Commission (SEC) has fined 16 major financial firms, including Barclays, Goldman Sachs, and Citigroup, a collective total of over $1.8 billion for failing to maintain and track employees' messages on personal devices. The investigation, which spanned from January 2018 to September 2022, revealed widespread
United States. Securities and Exchange Commission
The Securities and Exchange Commission's proposed climate rule has sparked a significant shift in the way real estate investment trusts (REITs) approach environmental, social, and governance (ESG) reporting. In a video interview at NAREIT's REITworks: 2022 Conference, Carol Samaan, vice president of corporate counsel and ESG
United States. Securities and Exchange Commission
Amgen Inc., a leading biopharmaceutical company, has filed a U.S. Securities and Exchange Commission (SEC) form 424B2, a prospectus form required for primary offerings of securities, on August 16, 2022. The filing includes information on the security being offered, including the price and method of distribution. As a publicly-traded
